Biodesix Inc.

• Position: TO WATCH - Company overview - Brief article

SNAPSHOT: Biodesix is a molecular diagnostic company that develops products to support clinical decision making and improve patient care. In 2009, the company introduced VeriStrat, a test based on a proprietary technology that helps physicians guide treatment for patients with non-small cell lung cancer.

[ILLUSTRATION OMITTED]

LEADERSHIP: David Brunel is chief executive officer of the Broomfield company, which was founded in 2005.

PIVOTAL MOMENT: Biodesix began as a small company funded by a few angel investors. Despite its small size and limited resources, the company published a landmark paper in June 2007 in the Journal of the National Cancer Institute that presented the development and validation of VeriStrat, its first commercial product. "This...